Darryl Auguste - 16 Feb 2023 Form 4 Insider Report for EverQuote, Inc. (EVER)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Feb 2023, 15:52:00 UTC
Prior SEC filing
18 Nov 2022
Next SEC filing
23 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John B. Wagner, as attorney-in-fact for Darryl Auguste

Key filing fact

Darryl Auguste filed Form 4 for EverQuote, Inc. (EVER) on 21 Feb 2023.

Key facts

  • This page summarizes Darryl Auguste's Form 4 filing for EverQuote, Inc. (EVER).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Feb 2023, 15:52.

Change

  • Previous filing in this sequence was filed on 18 Nov 2022.
  • Current net transaction value: -$19,359.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVER transaction

Class A Common Stock

Sale

Transaction value
$3,521
Shares
-223
Change %
-0.27%
Price
$15.79
Shares after
81,864
Date
16 Feb 2023
Ownership
Direct
Footnotes
F1, F2
EVER transaction

Class A Common Stock

Sale

Transaction value
$3,269
Shares
-207
Change %
-0.25%
Price
$15.79
Shares after
81,657
Date
16 Feb 2023
Ownership
Direct
Footnotes
F2, F3
EVER transaction

Class A Common Stock

Sale

Transaction value
$3,205
Shares
-203
Change %
-0.25%
Price
$15.79
Shares after
81,454
Date
16 Feb 2023
Ownership
Direct
Footnotes
F2, F4
EVER transaction

Class A Common Stock

Sale

Transaction value
$9,363
Shares
-593
Change %
-0.73%
Price
$15.79
Shares after
80,861
Date
16 Feb 2023
Ownership
Direct
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 16, 2023. The sales do not represent discretionary trades by the reporting person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.78 to $16.09, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Footnote F3

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2021, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 16, 2023. The sale does not represent a discretionary trade by the reporting person.

Footnote F4

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2021, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 16, 2023. The sales do not represent discretionary trades by the reporting person.

Footnote F5

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 16, 2023. The sales do not represent discretionary trades by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .